330 related articles for article (PubMed ID: 3545455)
41. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
42. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
Thorpe SM; Rose C
Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
[TBL] [Abstract][Full Text] [Related]
43. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
44. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
45. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
46. [Enzyme immunological measurement of estrogen receptors in the human endometrium by the use of monoclonal antibody].
Kato J; Hirata S
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):549-54. PubMed ID: 3290361
[TBL] [Abstract][Full Text] [Related]
47. [The expression of nuclear estrogen receptor and its relation to cytoplasmic estrogen receptor in breast cancer].
Yao XY
Zhonghua Bing Li Xue Za Zhi; 1992 Feb; 21(1):37-9. PubMed ID: 1319848
[TBL] [Abstract][Full Text] [Related]
48. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
49. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
50. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
Kubouchi K
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
[TBL] [Abstract][Full Text] [Related]
51. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
[TBL] [Abstract][Full Text] [Related]
52. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
Ferrer Roca OF; Ramos A; Diaz Cardama A
Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
[TBL] [Abstract][Full Text] [Related]
54. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies.
Thorpe SM; Lykkesfeldt AE; Vinterby A; Lonsdorfer M
Cancer Res; 1986 Aug; 46(8 Suppl):4251s-4255s. PubMed ID: 3015386
[TBL] [Abstract][Full Text] [Related]
55. [Comparative study of single-point method and multipoint method in the measurement of estrogen receptor and progesterone receptor in breast cancer].
Shen XQ
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):112-5. PubMed ID: 1618078
[TBL] [Abstract][Full Text] [Related]
56. Studies on estrogen receptors and regression in human breast cancer.
MacFarlane JK; Fleiszer D; Fazekas AG
Cancer; 1980 Jun; 45(12):2998-3003. PubMed ID: 7388744
[TBL] [Abstract][Full Text] [Related]
57. Relationship between ER-ICA and conventional steroid receptor assays in human breast cancer.
Di Fronzo G; Clement C; Cappelletti V; Miodini P; Coradini D; Ronchi E; Andreola S; Rilke F
Breast Cancer Res Treat; 1986; 8(1):35-43. PubMed ID: 3539238
[TBL] [Abstract][Full Text] [Related]
58. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays.
Mobbs BG; Johnson IE; Liu Y
Prostate; 1990; 16(3):235-44. PubMed ID: 1691841
[TBL] [Abstract][Full Text] [Related]
59. Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
